Patent details
EP2668212
Title:
HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
Basic Information
- Publication number:
- EP2668212
- PCT Application Number:
- EP2012051320
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP127017424
- PCT Publication Number:
- WO2012101252
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
- French Title of Invention:
- ANTICORPS HUMAINS CONTRE PCSK9 POUR UTILISATION DANS DES PROCÉDÉS DE TRAITEMENT DE GROUPES PARTICULIERS DE SUJETS
- German Title of Invention:
- MENSCHLICHE ANTIKÖRPER GEGEN PSCK9 ZUR VERWENDUNG IN VERFAHREN ZUR BEHANDLUNG BESTIMMTER GRUPPEN VON PERSONEN
- SPC Number:
-
Dates
- Filing date:
- 27/01/2012
- Grant date:
- 21/03/2018
- EP Publication Date:
- 04/12/2013
- PCT Publication Date:
- 02/08/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/03/2018
- EP B1 Publication Date:
- 21/03/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 27/01/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/03/2018
-
-
- Name:
- Sanofi Biotechnology
- Address:
- 54 rue La Boétie, 75008 Paris, France (FR)
Agent
- Name:
- ARONOVA S.A.
- From:
- 20/06/2018
- Address:
- PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- BESSAC, Laurence
- Address:
- France (FR)
2
- Name:
- HANOTIN, Corinne
- Address:
- France (FR)
3
- Name:
- CHAUDHARI, Umesh
- Address:
- United States (US)
Priority
1
- Priority Number:
- 11305088
- Priority Date:
- 28/01/2011
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 11305089
- Priority Date:
- 28/01/2011
- Priority Country:
- European Patent Office (EPO) (EP)
3
- Priority Number:
- 11305514
- Priority Date:
- 29/04/2011
- Priority Country:
- European Patent Office (EPO) (EP)
4
- Priority Number:
- 11305513
- Priority Date:
- 29/04/2011
- Priority Country:
- European Patent Office (EPO) (EP)
5
- Priority Number:
- 11306039
- Priority Date:
- 12/08/2011
- Priority Country:
- European Patent Office (EPO) (EP)
6
- Priority Number:
- 11306040
- Priority Date:
- 12/08/2011
- Priority Country:
- European Patent Office (EPO) (EP)
7
- Priority Number:
- 11306201
- Priority Date:
- 22/09/2011
- Priority Country:
- European Patent Office (EPO) (EP)
8
- Priority Number:
- 11306202
- Priority Date:
- 22/09/2011
- Priority Country:
- European Patent Office (EPO) (EP)
9
- Priority Number:
- 11306450
- Priority Date:
- 08/11/2011
- Priority Country:
- European Patent Office (EPO) (EP)
10
- Priority Number:
- 11306449
- Priority Date:
- 08/11/2011
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
-
A61J 1/05;
A61K 31/215;
A61K 31/366;
A61K 31/395;
A61K 31/404;
A61K 31/435;
A61K 31/47;
A61K 31/505;
A61K 39/00;
A61K 39/395;
A61K 45/06;
C07K 14/47;
C07K 16/40;
Publication
European Patent Bulletin
1
- Issue number:
- 201812
- Publication date:
- 21/03/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201817
- Publication date:
- 25/04/2018
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 01/02/2027
- Annual Fee Number:
- 16
- Annual Fee Amount:
- 230 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 16/01/2026
- Last Annual Fee Paid Number:
- 15
- Last Annual Fee Paid Amount:
- 213 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM